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ROLE OF THOMPSON SCORE IN PREDICTING NEURO DEVELOPMENTAL OUTCOME IN NEWBORNS.
Birth asphyxia is a condition of impaired gas exchange  occurring during labour leading to
progressive hypoxia associated with carbon dioxide retention and significant metabolic acidosis.It is an
important cause of perinatal mortality and neurological morbidity,Recently new technologies have
become available to determine cerebral damage more accurately and earlier in perinatal course.These
include computerized tomography (CT),magnetic resonance imaging(MRI),cerebral function
monitoring,cranial ultrasound and Doppler ultrasound of middle cerebral artery.These modalities are
not available in many neonatal units ,and certainly not in developing countries.There is a need for a
simple but accurate clinical method of predicting outcome.
AIM :To determine the ability of THOMPSON SCORE in newborn infant with HIE within 6 hrs of birth in
predicting neurodevelopmental outcome at 9 months of age.
JUSTIFICATION OF STUDY:Simplenon invasive clinical tool to select ideal candidate for neuro protective
therapy,to do early intervention like physiotherapy,developmental assessment, occupational therapy,to
minimize disability in future,to counsel the parents regarding prognosis early.
STUDY POPULATION:Child born with signs of HIE at birth are my study population.50 in each arm as
exposed  and unexposed group(including 10% lost to follow up)
Exposed-Thompson score more than 10
Unexposed-Thompson score equal  or less than 10
Study period-9 months
Methodology-Term infants of 37 weeks of gestation or more are selected with clinical signs of HIE at
birth.
INCLUSION CRITERIA-
BOTH 1 AND 2 SHOULD BE PRESENT
1)INFANTS>37 WEEKS OF GESTATION ADMITTED IN NICUWITH ANY ONE OF FOLLOWING:
A)APGAR Score<5 at 10 minutes of birth
B)Continued need for resuscitation including endotracheal or mask ventilation at 10 minutes after birth.
C)Acidosis within 60 minutes of birth( umbilical cord,arterial,or cord PH<7)
D)Base deficit>16 mmol/lin umbilical cord or any blood sample within 60 minutes of birth.
2)Altered state of consciousness(lethargy,stupor or coma)atleast one of the following
A)Hypotonia
B)Abnormal reflexes(oculomotor and pupillary abnormality)
C)Absent or weak suck
D)Clinical seizures.
EXCLUSION CRITERIA:
1)Infants> 6hrs of age
2)Major congenital abnormality or syndromes that include brain dysgenesis.
Infants scored by THOMPSON SCORE within 6 hrs of birth and for 7 consecutive days.Infants followed up
at 3,6,8 months of age.One cranial ultrasound should be done prior to discharge.Detailed neurological
and development assessment will be done every 3rd month.
It is a clinical tool comprising of a set of clinical signs associated with CNS dysfunction.
It is used to assess status of a child following birth asphyxia.
In scoring system,a score of 0 is normal and maximum score is 22 which signifies worst possible status of
HIE.
Infants scoring 1-10 are considered to have mild HIE,11-14 have moderate HIE,15-22 are considered to
have severe HIE.
This is modified sarnat scoring system.
Infant neurological assessment should be conducted usingDASI II by paediatrician.
Development activities screening inventory(DASI)II-It is designed for early detection of development
delay with special focus on young children with language impairment whose cognitive abilities may not
be accurately screened with a tool that requires the child to follow spoken instructions.DASI-II
instructions may be either verbal or visual.There are 67 items which can be administered in one or two
settings.
Description of scales
DASII scale is a point scale with items
arranged in ascending order or age placement
for both motor and mental scales.
The items in the two scales are classified
into content clusters under different areas of
development. There are five clusters of motor
items and 10 clusters of mental items.
Motor clusters
I. Neck control
II. Body control
III. Locomotion I (Coordinated movements)
IV. Locomotion II (Skills)
V. Manipulation
Mental clusters
I. Cognizance (Visual)
II. Cognizance (Auditory)
III. Reaching, manipulation and exploring
IV. Memory
V. Social interaction and imitative behavior
VI. Language I (Vocabulary and comprehension)
VII.Understanding of relationship
VIII. Differentiation by use, shapes and
movements
IX. Manual dexterity
The content clusters have great utility in
clinical practice. They may be used in analyzing
the child’s performance in each area of
development obtaining a profile of development
with indication of areas of delay in development.
It helps to plan intervention strategy with referenceto child’s strengths and weaknesses. It aids in effective
counseling of parents for home based stimulation program.
Differential diagnosis with DASII
It is possible not only to identify delays and areas of delays with DASII but cluster analysis
can also help in differential diagnosis.
A Down’s syndrome baby will have better motor than mental profile.A high functioning autistic child
will have almost normal motor profile and relatively low onmental but, especially low on language, social
interaction. He is likely to do better on memory,understanding of relationships or form boards.
A cerebral palsy child will score low onmotor items, imitative, skills but better on language
development, especially receptive language.He may do poorly on timed items, like
manipulation and manual dexterity clusters.A child with low stimulational and early
deprivation may show adequate score on motobut lower on mental clusters.
Thus, in trained hands, the DASII is a very comprehensive and effective tool often
considered the gold standard for developmentalassessment. It should be an integral part of any
developmental clinic where effective intervention is planned.
Points to Remember
• Developmental assessment should be an
integral part of NICU (Neonatal intensive
care unit)
• Developmental screening be done in all high risk infant as early as 3-6 months of
age
• DASII (Developmental assessment scales for Indian infants) is a very effective
comprehensive and useful tool which is standardized in Indian babies
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ROLE OF THOMPSON  SCORE IN PREDICTING 
NEURODEVELOPMENTAL OUTCOME. 
INTRODUCTION 
Perinatal  asphyxia  is  a  important  cause  of  perinatal  mortality  and  
morbidity. .Data from the National Perinatal database suggests that perinatal asphyxia 
contributes to almost 20% of neonatal death in India20. Failure to initiate or  sustain 
respiration after birth is the criteria for the diagnosis  of asphyxia by WHO20 . It  is  a    
condition  of  altered  gas  transfer  in  delivery of fetus causes CO2 excess  and  
abnormalities in acid base balance of the newborn. During labour  uterine arteries and 
veins get compressed by pressure causing distruption of flow  to placenta. .Uterus 
gets adequate blood only when it is relaxing in between contractions . There  is  slight  
fall  in  blood  PH  in  healthy  fetus  and  placenta  during  normal  labour.  Factors 
that prolong the normal labour or if adaptations in fetus is not successful then it 
results in fetal hypoxemia and significant metabolic acidosis .If it prolonged beyond 
certain period there is excess synthesis of lactic acids and this condition can leads to 
asphyxia . Excitatory  and  toxic  amino acids  accumulate  in  damaged  tissues.  
Sodium and calcium in the tissues becomes excess results in cytotoxic damage and 
cerebral edema.In tissues there is excess of free radicals and nitric oxide. Blood flow   
increases in ductus  venosus, ductus  arteriosus,  and  foramen  ovale  at the same 
time blood flow through the brain  ,heart  and  adrenals is continued  when compared  
to  lungs,  liver,  kidneys  and  intestine.  Post  asphyxial  neuronal  damage  is  high  
in  developing  countries.  Factors that determine perinatal  asphyxia  comprises of   
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fetal  or  umbilical  cord  pH  measurement,  intrapartum  electronic  fetal  monitoring  
,meconium  stained  amniotic  fluid, APGAR  score, hypoxic  ischemic  
encephalopathy, and  major  organ  disorder .New  technologies that are useful to 
know damage  in the grey matter and white matter include  computerised  
tomography(CT), magnetic  resonance  imaging(MRI), cerebral  function  
monitoring,  skull ultrasound  and  Doppler  ultrasound  of  middle  cerebral  artery. 
Above said techniques  are not used widely  in several  hospitals, especially in  
developing  countries .So we require a basic  tool at the same time accurate clinical 
method to know the neurodevelopmental outcome in newborns. 
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REVIEW OF LITERATURE 
Neonatal  Encephalopathy  16 
Neonatal  Encephalopathy  (NE)  is  explained   as a group of signs  of 
abnormal  neurological  function  in  the first few  days  of  life  in  the  term  infants,  
characterized by abnormalities in  tone  and  reflexes,  abnormal level  of  
consciousness  and it is usually  accompanied by neonatal  seizures.   
Several  important factors can cause neonatal  encephalopathy ,the most often 
it is due to  hypoxic-ischaemic  insult.  In deliveries when evidence of Hypoxic insult 
is not available other causes of neonatal encephalopathy should be looked for. 
Some factors that can leads to  NE  include:   
• infection   
• perinatal  stroke   
• intracranial  haemorrhage   
• congenital  brain  malformations   
• inborn  errors  of  metabolism   
• genetic  syndromes   
  Hypoxic ischemic encephalopathy is the main and most serious adverse event 
affecting term newborns. Hypoxic ischemic encephalopathy is used  to describe  
19 
 
neurological  syndrome  that is occurring secondary to perinatal  asphyxia .It  occurs  
in  1.5  to  2.5  per  1000  live  births  in  developing  countries.6.Gilstrap et al  
precisely describe birth asphyxia which occurs at time of birth and it is determined by 
umbilical artery   pH, Apgar score and  the newborn neurological status. Depression 
of the newborn defined by APGAR <3 at 1 and 5 minute  and umbilical arterial pH 
<7.019 
Five processes  of  perinatal  asphyxia include: 
1.  Interuption of umbilical circulation 
2.  Inadequate blood flow to placenta on the maternal side 
3. Gas exchange abnormalities in the placenta. 
4.  Inability of the newborn to  maintain lung inflation and problem in moving 
from   fetal to adult circulation. 
5.  Altered maternal oxygenation 
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 World Health Oragnization Failure to initiate and sustain breathing  
NNPD Network 
 
 
  
• Moderate PA: Slow/gasping 
breathing or an Apgar score of 
4 to 6 at 1 minute  
• Severe PA: No breathing or an 
Apgar score of 0-3 at 1 minute 
of age  
 
American Academy of Pediatrics and 
American College of Obstetrics and 
Gynecology 
Presence of all of following criteria:  
• Profound metabolic or mixed 
acidemia (pH< 7.00) in 
umbilical cord blood  
• Persistence of low Apgar scores 
less than 3 for more than 5 
minutes  
• Signs of neonatal neurologic 
dysfunction (e.g., seizures, 
encephalopathy, tone 
abnormalities)  
• Evidence of multiple organ 
involvement (such as that of 
kidneys, lungs  
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Newborns response to asphyxia in two manners 
1. Centralization of fetal circulation with excess flow to adrenals, heart and brain 
2.   Process of  Erythropoiesis  becomes more with the excess of immature RBC in  
peripheral veins. This is responsible for excess of nucleated RBC following 
perinatal asphyxia. 
CIRCUMSTANCES THAT DETERMINES  CNS INSULT: 
• Cellular susceptibility(neurons most susceptible) 
• Vascular territories(Water shed areas) 
• Regional susceptibility(areas of higher metabolic rates i.e,Thalamus) 
• Degree of asphyxia 
ETIOLOGY2 
.
.It  mainly occurs when cerebral perfusion is so  less so that O2 extraction cannot be 
done from the venous and arterial circulation. As a result oxidative metabolism and 
cerebral blood flow mis match with each other. The multiple factors that can leads to 
HIE are 
  Include maternal hypotensive states, infertility in the mother,,thyroid disease. 
 Intrapartum risk factors include maternal fever, breech presentation, difficult  
forceps delivery, abruption placenta or cord prolapse. 
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 Post natal factors such that sepsis,  shock, congenital heart disease and severe 
respiratory distress 
EVOLUTION OF HIE CHANGES20. 
It is slow ongoing mechanism which  starts from the injury phase and can 
extend and can continue after resuscitation phase. At first, insult to the brain is 
because of ischemia and further injury is because of reperfusion. Penumbra is the 
region around the infarcted zone .  Penumbra zone will continue to reveal features of 
apoptosis and necrosis once hypoxic insult finishes . PERIOD OF DELAYED 
NEURONAL INJURY   is not understood  but  extend   from 24 - 48 hours then start 
to resolve. 
Additional factors  that  influence outcome are nutritional status of brain, 
severe intrauterine infection, pre-existing brain pathology, and frequent seizure 
disorder20. 
Hypoxic ischemic encephalopathy  
It result from a hypoxic process that takes place during the periods of prenatal, 
intrapartum and postnatal time period.6 Death, disabilities  like seizures 
developmental delay and cerebral palsy is the outcome in 60% on newborns born 
with hypoxic ischemic encephalopathy. Majority  of  underlying  events  of  HIE  due  
to  impaired  supply of O2 to  the  brain  and  it due to reduced supply of blood to 
brain. 
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PATHOLOGY OF INJURY  
Insults could be of many varieties and it based on time and extend of the injury.. 
1) GLOBAL ISCHEMIA 
 Global ischemia occurs  when oxygen requirements for cerebral metabolism 
are unable to met by cerebral perfusion pressure or due to decrease in cerebral 
arterial or an increase in cerebral venous pressure . 
The duration of the insult is inversely proportional to the gestational age of the 
fetus . The latent period vary from hours to days and is determined by various 
factors like vascular,cellular and metabolic factors. 
FOCAL OR PARTIAL  ISCHEMIA  
It occurs when artery or venous supply to a region is compromised. The 
injured region typically consists of central dense region of  ischemia that  
undergoes rapid cell death and the core surrounded by a region  of evolving 
cell injury called penumbra .The cells in the penumbral region initially 
sustained by anaerobic glycolysis. If the injury  is sustained penumbra is 
transformed in to region of infarction .This period of delay in cell death 
provides an opportunity for therapeutic intervention. 
2) Partial asphyxia with normal acid base balance is due to hypotensives states in 
mother ,due to decrease  in exchange of gases in placenta,and reduced placental 
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blood flow.This leads to extensive  cortical necrosis or  posterior parietal 
parasaggital injury.  
3) Partial asphyxia associated with acid base abnormalities leads to injury  to white 
matter. Systolic BP maintain blood flow to the brain. It maintains the blood supply 
by dilates the arteries to the brain structures..Basal ganglia,thalamus and brain 
stem nuclei are susceptible to  injury due to either excess myelination and excess 
of glutaminergic synapses. 
VARIOUS TYPES  OF NEUROLOGICAL  INJURY 
 Parasaggital lesions 
 Status marmoratus 
 Focal or multifocal necrosis 
 Spinal cord ischemic infarction 
 Periventricular leukomalacia 
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SELECTIVE NEURONAL NECROSIS 
LONGER THE INJURY-Involves cortical and subcortical areas 
SHORTER THE INJURY-Involves thalamu,basal ganglia and brain stem. 
Posterior parietal-occipital region is more prone to injury than anterior cortical 
areas. 
 CORTICAL INJURY-Seizures 
 BASAL GANGLIA AND THALAMUS-Irritability, posturing, and brain 
stem dysfunction. 
PARASAGITTAL INJURY-CLINICAL FEATURES 
 Weakness and hypotonia in the upper trunk 
STATUS MARMORATUS 
It refers to characteristic picture of a marble in cerebral cortex and basal ganglia and 
thalamus.It is commonly  associated with choreo athetoid cerebral palsy in children. 
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FOCAL CEREBRAL NECROSIS 
  It results from a area of infarcted zone secondary to thrombus or embolus.. 
Main factors which predisposes this condition are increased platelet count, ITP, 
vascular malformation, and if the mother uses excess cocaine. 
PERIVENTRICULAR LEUKOMALACIA 
In preterm babies it involves predominately white matter and results in 
extensive injury to that areas. Focal necrosis and development of cyst and extensive 
injury to precursors of oligodendrites is the characteristic feature of periventricular 
leukomalacia.. 
OUTCOME is mostly in the form of spastic  diplegic cerebral palsy and motor 
deficit. 
RISK FACTORS FOR PERIVENTRICULAR LEUKOMALACIA 
 Seizures 
 Sepsis 
 Recurrent episodes of apnea 
 Asphyxia 
 Prolonged ventilation 
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PATHOGENESIS. 
It is divided in to four phases 
1) membrane depolarization due to fall in energy in grey matter. 
2) Pouring of  Neurotransmitters and causes extensive injury to the neurons 
3) A period of reperfusion 
4) A final phase of irreversible cell death. 
PHASES OF INJURY DURING REPERFUSION 
 FIRST PHASE 
 Cerebral energy metabolism restored over 30 minutes 
 Resolution of acute cellular hypoxic depolarization and cell swelling. 
 LATENT PHASE 
 Near normal oxidative cerebral metabolism 
 Depressed electroencephalogram and reduced blood flow. 
 SEONDARY ENERGY FAILURE 
 Inhibition of oxidative phosphorylation 
 Cytotoxic edema leading  to delayed seizures. 
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PHASE OF REPERFUSION 
This period extends from 6 hours to 15 hours before cell death and provide an 
opportunity of therapeutic window. This phase is characterized by reduced blood 
supply to the brain and Electroencephalogram activity is reduced..This phase occurs 
during the return of blood flow and adequate O2 supply to the brain. 
PHASE OF IRREVERSIBLE CELL DEATH 
This process results in two different types of death in the brain celli.e 
Apoptosis and Necrosis 
 APOPTOSIS-It is due to shrinkage of nucleus,,condensed forms of chromatin 
and disintegration of DNA .It occurs due to chronic cellular injury. 
 NECROSIS-It is due to cellular swelling, plasma membrane disintegration, 
extensive inflammation in the cells. 
The   pathophysiology of  HIE is primary  energy  failure  and  other  one  is  
secondary  energy  failure. 
PRIMARY  ENERGY  FAILURE: 
Decreased in blood supply to white and grey matters in the brain causes fall in 
O2 and glucose levels in brain leads to excess lactate content and reduced ATP in the  
brain. This leads to Na-K pump failure and accumulation of Na inside the cells. This 
mechanism fails to maintain Ca levels inside the cells. This results in increased 
amounts of glutamate. Necrosis and apoptosis results from ischemia, damage in the 
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blood vessels, and edema inside the cells. If the hypoxia is very severe , results in 
ischemic necrosis.  
Cell begins to increase in size and resulting in rupture leading to death of the 
cells. There is additional influx of inflammatory mediators produced by microglial 
cells. Resulting inflammation .causes scar formation. 
Functions of the brain cells decreased due to apoptosis and necrosis. Death 
occurs to the neuronal cells if ischemia is so severe and it is through necrosis of brain 
cells 
 There is period of recovery occurs once the blood flow is returned. This phase 
is called as latent period of cell death. Optimum time for therapeutic intervention is 
determined by the latent period. Extensive the insult shorter is the latent period. 
30 
 
 
 
FIGURE  1.PATHOPHYSIOLOGY OF HYPOXIC ISHCHEMIC 
ENCEPHALOPATHY 
 
v*  =  increased;  =  decreased;  PaO2  =  arterial  oxygen;  Na+  =  sodium;   
K+  =  potassium; 
ATP  =  adenosine  triphosphate;  Ca2+  =  calcium;  NMDA  =  N-methyl-D-
aspartate;  AMPA  =∝-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic  acid;  ROS  
=  reactive  oxygen  species; 
NO  =  nitric  oxide;  DNA  =  deoxyribonucleic  acid. 
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• The brain is main control centre of the body. It is made up of nerve cells 
(neurons) that carry messages to and from the body.  
• Neurons receive messages from the body with every activity.. 
• They also send messages to the body to do things like control  muscles and 
movement .When these cells are damaged, the brain may not be able to receive 
and process information from the body, or send messages to parts of the body. 
• Based on the functions of neurons the brain is divided into different areas. 
Some areas involve muscle control , while other areas are related to vision and 
hearing. Depending on the area affected by the lack of oxygen, neonate will 
have difficulties with the activities controlled by that specific area. 
There are many possible areas of  brain that may have been affected. However, 
the most common areas are the cerebral cortex, basal ganglia ,brainstem and 
thalamus.. 
. 
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FIGURE  2.LOCATION  OF  BRAIN  STRUCTURES  IMPACTED  BY  
TREATMENTS 
 
CNS STRUCTURES SUSCEPTIBLE TO ISCHEMIC INJURY DEPENDS ON 
THE GESTATIONAL AGE 
• For babies <20 weeks-Insults leads to neuronal heterotopia 
• For babies 26-36 weeks-Insults mainly affects white matter leading to 
periventricular leukomalacia. 
• For term newborns-Insults primarily affects grey matter 
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FIGURE -3  
Secondary  Energy  Failure 
This process results 6 hours to 48 hours after primary energy failure.  The   
exact  mechanisms  remain  unknown12 but  it occurs due to  oxidative  stress,  
excitotoxicity,  and  inflammatory process. Excess free radicals causes disintegration 
of cell membranes of the neurons which results in apoptosis and necrosis. This 
process is called as oxidative stress.   
This stress is harmful to neonatal brain and its structures because antioxidants  
levels in neonatal brain is too low and because it utilizes more oxygen when a 
transition  occurs from fetal to neonatal life. In the neonatal brain free iron is 
responsible for the formation of free radicals. 
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Another important cause of injury is due to release of excitatory 
neurotransmitters namely  glutamate  which in turn stimulate excitatory receptors 
results in influx of Na and Ca into the cells. 
Glutamate a excitatory neurotransmitter is a predominant neurotransmitter in 
pathways like vision, hearing and intellect, results in abnormalities in conduction of 
these pathways in HIE. 
Inflammation mediated  brain injury also occurs in Hypoxic ischemic 
encephalopathy. Supportive treatment of HIE is management of seizures and 
cardiopulmonary support. 
CLINICAL FEATURES:2 
           Clinical   signs and symptoms depends on timing, duration and severity of 
insult. Consider infant gestational age while looking for clinical features. Symptoms 
evolve over a period of 72 hours. Cerebral hemisphere depression is responsible for 
signs and symptoms in first 12 hours of life although sign of brainstem involvement 
is there. 
Infant is not easily arousable  during this period .Involvement of reticular 
activating system, brain stem and thalamus results in alteration of consciousness. 
Hypotonia jitteriness, seizures in the first 12 hours of birth due to extensive 
involvement of cortex.. Seizures in first 2 to 3 hours indicate severe asphyxia. 
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Seizures in term infants is usually focal. Subtle seizures is characterized by 
movements of the eyeballs like conjugate deviation of eyes, blinking or constant 
opening of eyes. 
There is apparent increase level in alertness during 12 to 24 hr after injury  but 
it is improvement of neurological function is not apparent in this period.. Seizures, 
apnea and jitteriness accompany this period. Deep tendon reflexes and moro reflexes 
are exaggerated there is weakness in proximal limbs 
 especially consciousness levels. The clinical condition of newborn comes 
down beyond 24 -48 hours. Sometimes outcome is so severe that leads to death 
,absent DEM ,poor suck and diminished tone and proximal muscle weakness. 
When a neonate suffer asphyxia during   labour, some of them develop HIE 
with outcome ranging from complete recovery to death. 
 
 
 
Convulsion in the newborns mostly caused by the hypoxic ischemic 
encephalopathy. But it can be due to antenatal, intrapartum and postnatal causes. 
Postnatal factors that leads to seizures account for 10% of the cases. 
HIE can be suspected in any newborn born but to confirm HIE biochemical 
parameters are necessary. It includes four main and important features 
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As suggested by AMERICAN COLLEGE OF OBSTETRICS AND 
GYNECOLOGY. 
These main cardinal features are 
• Umblical cord blood pH <7 with profound metabolic or mixed academia 
• Apgar <3 after five minutes of birth 
• Neurological sequelae like convulsions, coma and decreased tone of newborn. 
• MODS(Significant hematological, cardiovascular., gastrointestinal 
dysfunction) 
 
 
 
CLINICAL STAGING OF HYPOXIC ISCHEMIC ENCEPHALOPATHY 
 
FACTORS STAGE1 STAGE2 STAGE3 
LEVEL OF 
CONSCIOUSNESS 
ALERT LETHARGY COMA 
MUSCLE TONE NORMAL HYPOTONIA FLACCIDITY 
TENDON REFLEXES NORMAL/ 
INCREASED 
INCREASED DEPRESSED/ 
ABSENT 
MYOCLONUS PRESENT PRESENT ABSENT 
SUCKING ACTIVE WEAK ABSENT 
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MORO EXAGGERATED INCOMPLETE AB 
SENT 
GRASPING NORMAL EXAGGERATED ABSENT 
OCCULOCEPHALIC NORMAL OVERACTIVE REDUCED 
 
Differential Diagnosis of Neonatal Seizures*                                              
Metabolic                                                                    
 
Hypoxia-ischemia (i.e., asphyxia) 
Hypoglycemia 
Hypocalcemia 
Hypomagnesemia 
Hypoglycemia 
Glycogen storage disease 
Galactosemia 
Intracranial hemorrhage 
Subarachnoid hemorrhage 
Subdural/epidural hematoma 
Intraventricular hemorrhage 
Cerebrovascular lesions (other than trauma) 
Cerebral infarction (thrombotic vs. embolic causes) 
Ischemic vs. hemorrhagic lesions 
Cortical vein thrombosis 
Circulatory disturbances from hypoperfusion 
 
Idiopathic 
 
Hypomagnesemia 
Infant of a diabetic mother 
Neonatal hypoparathyroidism 
Maternal hyperparathyroidism 
High phosphate load 
Other electrolyte imbalances 
Hypernatremia 
Hyponatremia 
 
Cerebrovascular lesions (other than 
trauma) Cerebral infarction 
(thrombotic vs. embolic causes)  
Ischemic vs. hemorrhagic lesions 
cortial vein thrombosis 
circulatory disturbances from 
hypoperfusion  
Infections 
Bacterial meningitis 
Viral encephalitis 
Congenital infections 
Herpes simplex 
Syphilis 
Cytomegalovirus infection 
Drug withdrawal or toxins 
Prenatal exposure to substances of 
abuse—methadone, 
heroin, barbiturate, cocaine 
Prescribed medications—
propoxyphene, isoniazid 
Local anesthetics 
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Coxsackie virus meningoencephalitis 
Toxoplasmosis 
Acquired immunodeficiency 
syndrome (AIDS) 
Brain abscess 
 
Familial seizures 
Neurocutaneous syndromes 
Tuberous sclerosis 
Incontinentia pigmenti 
Autosomal dominant neonatal 
seizures 
 
Amino acid metabolism 
Branched-chain amino acidopathies 
Urea cycle abnormalities 
Nonketotic hyperglycinemia 
Ketotic hyperglycinemia 
 
Brain anomalies  
(i.e., cerebral dysgenesis from either congenital or acquired causes) 
 
Hypertensive encephalopathy 
Selected genetic syndromes 
Zellweger  syndrome 
Neonatal adrenoleukodystrophy 
Smith-Lemli-Opitz syndrome 
 
 
  
 
 
HIE can be classified as mild, moderate and severe based on clinical features 
• In mild HIE, infant is hyper alert, uninhibited reflexes and sympathetic over 
activity. 
• Moderate HIE is characterized   by depressed   reflexes,  hypotonia , seizures, 
stupor and lethargy. 
• .In severe HIE there is coma , hypotonia, suppressed brain stem function 
,seizures and  increased  intracranial pressure. 
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Severity of HIE in a newborn can be assessed by classification given by Levene. 
Cerebral lesions characterized by seizures, mental retardation and motor deficits. 
Basal ganglia lesion characterized by choreo -athetosis and rigidity. The lesion in the 
basal ganglia is characteristically called as status marmoratus. Extra pyramidal 
abnormalities appear late often later than one year.  Spastic diplegia mostly involving 
lower limbs than upperlimbs in premature born   infants causing motor deficits 
resulting neurological sequale is periventricular leukomalacia.  Diagnosis of cerebral 
palsy should be done at earliest so that we can institute therapy  earlier.  
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HIE:18The Sarnat and Sarnat classification identifies 3 levels or   grades  of 
severity of  
• GRADE 1(MILD) HIE: Characterized by active tendon  reflexes 
hyperalertness, mydriasis, jiterriness, but they don’t have seizure. Majority of 
such babies may have normal neurological outcome. 
• GRADE 2(MODERATE) HIE: Characterized by lethargy, poor feeding, 
decreased primitive reflexes, hypotonia, seizures and miosis. Such babies have 
25-45% risk of death or significant disability. 
• GRADE3 (SEVERE) HIE: Characterized by stupor, coma, marked hypotonia 
with intermittent decorticate posturing, irregular respiration, and absent 
primitive reflexes. Newborns in this have 90% chances of death or more 
severe neurological sequele. 
• Durations of symptoms in mild HIE is less than 24 hours,and in moderate HIE 
IS 2 TO 14 days and in severe HIE it is hours to weeks. 
• Outcome-MILD HIE-About 100% normal outcome 
MODERATE HIE-80% HAVE NORMAL OUTCOME,ABNORMAL ONLY 
IF SYMPTOMS PRESENT MORE THAN FIVE TO SEVEN DAYS. 
SEVERE HIE- DEATH 50% OF NEWBORN ,50% OF NEWBORNS HAVE 
SEVERE NEUROLOGICAL SEQUELAE. 
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Apgar score will not predict outcome in newborn born with HIE. However 
predictive value increases if Apgar is continues to be in low values. Neurological 
abnormalities three times more common if the Apgar is less than 6 at five minutes of 
birth. 
 Incidence of long term complications in mild HIE is low 
 In moderate HIE 20 to 40% chances of abnormal outcome 
 In severe HIE outcome is usually death within first few days after birth or 
newborn have neurological deficit . 
Depressed primitive reflexes with hypotonia and respiratory problems in the 
form of apnea indicates poor outcome in newborns with HIE. 
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CLINICAL FEATURES OF SEVERE HIE IN TIME FRAME20 
Birth to 12 hours   Depressed level of alertness, periodic 
breathing or respiratory failure, intact 
pupillary and occulomotor responses, 
hypotonia, seizures  
12 to 24 hours   Variable change in level of alertness, 
more seizures, apnoeic spells, 
jitteriness, weakness in upper and 
lower limbs, upper>lower (full term), 
hemiparesis (full term), legs 
(premature)  
24 to 72 hours   Stupor or coma, respiratory arrest, 
brain stem pupillary and occulomotor  
disturbances, catastrophic deterioration 
with severe intra ventricular 
hemorrhage and periventricular 
hemorrhagic infarction (premature)  
After 72 hours   
 Abnormal suck reflexes, swallowing, 
gag and abnormal tongue movements, 
diminished tone in limbs, weakness in 
proximal limbs, upper>lower (full 
term), hemiparesis (full term), lower 
limbs or hemiparesis 
(premature),stupor  
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CLASSIFICATION OF HIE BASED ON LEVENE STAGING20 
 
 Mild   Moderate   Severe  
Consciousness  Irritable  Lethargy   Comatose  
Tone  Hypotonia  Marked 
hypotonia  
 Severe hypotonia  
Seizures  No  Yes   Prolonged  
Sucking/respiratio
n  
Poor suck  Unable to suck   Unable to sustain 
spontaneous 
respiration  
 
RADIOLOGICAL FEATURES: 
In term infants blood flow is  ventriculofugal and changes are mainly in 
watershed border zones namely parasaggital grey matter and subcortical white matter 
.Severe HIE in term babies results in basal ganglia ,thalamic as well as sensorimotor 
cortex ( perirolandic region) injury. 
PATTERNS OF NEONATAL ISCHAEMIC BRAIN INJURY: 
• IN LESS THAN 28 WEEKS- 
Hydrancephaly and porencephaly and  immature brain not able to react with 
gliosis and liquefied brain parenchymal defect and enlargement of CSF spaces. 
• PERIVENTRICULAR-INTRAVENTRICULAR HAEMORRHAGE 
Occur  usually between 28  to 32 weeks and starts from  the germinal matrix 
zone of sub ependymal regions It is a important zone in a newborn which is 
capable of producing cells ,neurons and glial cells in the fetus.. Prematurity 
and number of capillaries has a direct correlation. 
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• SUBCORTICAL  LEUKOMALACIA  AND  PERIVENTRICULAR  
LEUKOMALACIA: 
Occurs usually between 32 and 36 weeks.Pathology behind this is extensive 
coagulation necrosis of the white matter on either sides.results in the formation 
of cavity lateral to the lateral ventricles and reduced myelination of the nerve 
fibres and extensive white matter loss. Both are a continuous disease spectrum, 
vascular border zones shift toward periphery brain matures further.. For this 
reason, White matter lesions move from periphery to subcortical zone. 
• HYPOXIC ISCHAEMIC ENCEPHALOPATHY OF THE TERM 
NEWBORN: 
If the hypoxic ischemia is more severe multicystic  encephalomalacia results 
.If hypoxic ischemia is less severe lesions common in high oxygen demand  
areas such as deep grey matter..  
HIE SCORE 
       Neurological status of a newborn can be predicted by this score. 
       Numerous  scoring systems have been used in various studies. Portmann found a 
score to assess morbidity and mortality in earlier days of life. The most widely used 
scoring system for the infants with HIE is sarnat and sarnat.. MILD,MODERATE 
AND SEVERE Groups. To classify the newborn into three types is so difficult in this 
staging system. Outcome of the newborn in moderate group is also unpredictable.. 
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However scoring system needs EEG and other laboratory values is unavailable in our 
hospital setup.  
Scoring system used by Thompson is numeric and it also includes lesser 
variables. It is much simpler and it is based on  Sarnat and Sarnat scoring system. The 
score consists of nine signs namely, level of consciousness, posture ,tone, 
reflexes(Moro, sucking ,grasp) seizures, respiration and based on anterior fontanel 
tension. 
Score of each sign   range from 0 to 3 and total score for each day is 
documented. 
More severely affected infant will have highest score. 22 is the highest score 
of newborn .It cannot be applicable in paralyzed newborns.In newborns who are on 
ventilators it is applicable equally. 
 
 
 
 
 
COMPONENTS OF THE HIE SCORE: 
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From the previous studies it was known that positive predictive values of 
Thompson score for predicting poor outcome in moderate and severe HIE is 90% and 
100% respectively and negative predictive value for the scoring system was 81.4%  
sekala D et al. 
C Thompson et all stated that sensitivity and specificity   Thompson score in 
predicting neurodevelopmental outcome is 100% and 93% respectively. 
Alon R Horn et all stated that Thompson score has 100% sensitivity and 61% 
specificity in predicting neurodevelopmental outcome. 
Wilkinson et all stated that Sarnat staging has sensitivity of 100% and 
specificity of 93%  in predicting outcome. 
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Boubou Hallberg et all stated that at one year of age Thompson score has high 
predictive value of 92% with a peak score of 15 and above and negative predictive 
value of 82% for abnormal outcome. This score has widely introduced because it 
predicts neurological outcome during first hours of life as compared to sarnat score, 
which is reliable after 24 hours. 
C Thompson et all stated that  positive predictive value and negative predictive 
value for initial  HIE score more than 10 in predicting neurodevelopmental outcome 
was 65% and  100 % respectively and sensitivity and specificity was 100% and 61% 
respectively. 
Other studies used clinical grading system to predict neurological outcome  
like  post asphyxial score of Lipper which uses 17 items which  will predict as early 
as 24 hours .Another system used was Bao assessment but it requires a training 
course of 2 weeks. 
Robert and finer proposed perinatal factors to predict neurological outcome in 
moderate encephalopathy group and suggest that newborns can be discharged at an 
early age from follow up. 
 Cerebral  Function  Monitoring  16 
It is used to document electrical activity of the brain in the form of 
Electroencephalogram . Global   or   hemispheric   electrical  activity  is  provided  by  
a EEG .It can single or dual time compressed and filtered electroencephalogram. 
However it  is not easily accessible in developing countries. 
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 Document electroencephalogram before giving phenobarbitone but if the EEG 
is not accessible treatment should not be delayed. 
ULTRASOUND SCAN OF THE SKULL 
   Many newborn conditions can mimic like Hypoxic ischemic encephalopathy 
and these conditions should be ruled out before starting cooling therapy. Ultrasound 
scan should be done to know the resistance index. 
Resistance   Index   
It is usually done in newborns with suspected HIE and it is done in first few 
days of life. If the value of resistance index is less than 0.55 it is usually associated 
with poor prognosis. It indicates abnormal blood flow to the brain most probably 
dilatation of blood vessels of the brain 
    HIE   findings  in  cranial  ultrasound:   
1. generalised  increase  in  echogenicity,  indistinct  sulci  and  narrow  
ventricles  usually denotes cerebral edema 
2. More  echogenicity  of  thalami  and  parenchymal  echo densities in the 
first few days of life.   
3.  (Resistive  Index  <0.55)  in  anterior  cerebral  artery  indicates adverse 
prognosis 
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4. When there is increased  velocity of blood flow in the end diastole when 
compared with systolic flow of blood predicts poor prognosis. 
Magnetic   Resonance  Imaging  (MRI) 
 
Abnormalities are well seen on T1-weighted magnetic resonance image  
• It is mainly used to confirm HYPOXIC ISCHEMIC ENCEPHALOPATHY 
and assess the outcome in newborns 
• It cannot diagnose injury level when done in the first few days of life 
• It is usually done in first few days of life when intraventricular hemorrhage 
being suspected. 
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• Diagnosis and outcome of the newborn can be assessed in newborns with HIE 
when done in tenth day of life. 
• In conditions like abruption placenta MRI findings are thalamus and basal 
ganglia lesions and posterior limb of internal capsule abnormalities 
• PLIC is associated with poor prognosis. 
• Cortex lesions are more common with prolonged duration of hypoxia. 
.  
MR image shows loss of signal intensity in the posterior limb of the internal 
Capsule. 
 
MAGNETIC RESONANCE SPECROSCOPY 
Magnetic Resonance Spectroscopy.  
• Magnetic resonance spectroscopy findings predicts accurate progonosis. 
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• if is abnormal it indicates poor prognosis. 
• It accurately predicts cognitive and neurological outcome. 
• Chronic insults to brain results in the formation of lactate and N-acetyl 
aspartate in the brain 
• When glucose metabolized anaerobically results in the production of lactate 
levels in the first day  and increased persistently remain high after 24 hours 
• N-acetyl aspartate will not come down to normal levels after 48 hours 
• N-acetyl aspartate start to decrease but exact duration is unknown Magnetic 
resonance spectroscopy can very well predicts convulsions in newborn and 
predict metabolic abnormalities in newborn than doing  imaging studies like 
MRI and CT scans. 
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The MR spectra show elevated lactate and decreased N-acetyl aspartate (NAA) peaks 
in the basal ganglia in that area CT  SCAN17:It cannot diagnose grey matter lesions 
when compared to MAGNETIC RESONANCE IMAGING 
TREATMENT: 
1) Whole body hypothermia 
2) Maintain   normal   blood   glucose. 
3) Maintain   normal   blood   pressure. 
4)  prevent   or  control  seizures  
5)  prevent   or  minimize  cerebral  edema. 
Stabilisation  of  babies  post-resuscitation  and  initial  management  where  
there  is  a  risk  of  or  diagnosed  HIE  18 
Initial management20 
Transfer the baby to special care newborn unit. 
Arterial blood gas analysis should be done in all babies with HIE. Those 
babies with respiratory difficulties needs to be admitted in neonatal intensive care 
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unit and should be monitored intensively. Newborns with mild HIE  transferred to 
mothers. Frequent monitoring is needed in these infants. Severe asphyxiated   infants 
need to be transferred  to NICU. 
Maintain temperature 
Thoroughly dry the newborn and place the newborn in the warmer.. Adverse 
outcome can occur due to hypothermia or hyperthermia. Metabolic demands of the 
newborn will be excess if the newborn  develops  hypothermia. It will add some 
stress to newborn .This excess stress will cause problems like acid base 
abnormalities. reduced blood pressure, cardiac arrest and pulmonary hemorrhage. 
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Urgent requirements  for  airway,  ventilation  and  circulatory  support  are  
assessed  and  managed   
   Intubate  and  ventilate  if  the  spontaneous  breaths  are  inadequate,  
desaturation  despite  oxygen,  blood  gases  shows  respiratory  failure,  
features  of   obtundation,  or  early  occurrence  of  seizures   
   Volume  replacement  indicated  where  there  is  suspected  blood  loss,  poor  
perfusion,  hypotension. 
Monitor  glucose levels in the blood and packed cell volume and arterial blood 
gas analysis. Utmost importance should be given to maintain hyperoxia, hypocarbia 
and hyperglycemia in first 48-72 hours  because these will cause irreversible injury to 
the newborn grey matter and white matter which is already injured. 
Respiratory   
• Monitor  oxygen  saturations  with  a  pre-ductal  target  of  90  –  95  %   
• In  ventilated  babies  maintain  pCO2  at  35-45  where  possible.   
• Many   babies   with   HIE  will  spontaneously  hyperventilate   
• Maintain  pH7.35-7.45. 
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Cardiac   
• Attach  cardiac  monitoring   
• Monitor  non-invasive  blood  pressure  where  arterial  access  is  not  
available.  Normal   mean   arterial  BP  should  be  >  40.  Pending  arterial  
line  placement,15  minutely  Doppler  measurement  must  be  recorded   
• A  baseline  bradycardia  (80  –  100)  is  common with  hypothermia,  
therefore  adjust  the  low  alarm  to  80  bpm. 
• Hypotension  is  a  common  sequale  of  myocardial  ischemia   
• If  hypovolumia  is  suspected  give  10–20  mL/kg  of 0.9%  sodium  chloride. 
Inotrope   therapy  may  also  be  needed 
Fluids   and  electrolytes   
• Insert  a  nasogastric  tube  and  keep  this  on  free  drainage.  Do  not  feed  
because  of  risks  of  ischemia  of  gut  and  airway  compromise   
• Insert  an  IV   
• Don’t give excess fluids  
• Check plasma  glucose  level  and  maintain  it    above  3.5  mmol/L   
• Fluid  restriction  is  essential  because  of  the  risks  of  syndrome  of  
inappropriate  of  antidiuretic  hormone  secretion  and  renal  failure.   
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• Glucose  infusion  rate  should  be  approximately    4  mg/kg/min  of  10  %  
glucose. To  avoid  hypoglycemia, higher  glucose  concentrations  are  
required. 
• Monitor  urine  output  via  weighed  nappies   
• Take  baseline  electrolytes  and  ionised  calcium   
Neurological   
• Perform  a  complete  neurological  examination  to  determine  the  
presence  and  severity  of  HIE   
• Treat  all  clinically  evident  seizures  with  phenobarbitone.   
Initially  20  mg/kg/dose  increased  up  to  40  mg/kg  (total)  over  the  first  24  
hours   
• Seizures  due  to  HIE  are  often  refractory  to  treatment   
• Hypermetabolic  cell  death  can  occur  due  to  seizure  activity. Treatment20 
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A)ADEQUATE VENTILATORY SUPPORT 
• Babies with respiratory distress and respiratory failure needs to intubated and 
connected to ventilator support. 
• Some babies born with apnea .It is essential to intubate those babies in labour 
room and connected to ventilator when shifted to neonatal intensive care units 
• Monitor arterial blood gas analysis if it shows hypoxia persisting it is essential 
to give ventilator support to those babies. 
• Maintain spo2 between 90 to 93% in preterm babies 
• Those babies with spontaneous breathing give oxygen through hood 
B)  MAINTAIN PERFUSION 
• Dopamine and dobutamine should be initiated once babies develops features 
of shock. 
• Monitor urine output continuously 
• To assess the perfusion use parameters like blood pressure ,CRT, ABG. 
• Perfusion is most important to be monitored in newborns with HIE. 
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C) VOLUME EXPANSION 
Normal saline and RL is most commonly used fluids to maintain intravascular 
volume. 
D) VASOPRESSORS 
• 3-5 microgram/kg/min is the ususal dose of dopamine 
• Increase the dose upto 10 microgram/kg/min in stepwise manner. 
• It can be reached upto 20 if the features of shock still persisting. 
• 5microgram/kg/min is the usual starting dose of dobutamines 
E)MAINTAIN NORMAL BLOOD GLUCOSE 
• Increased blood glucose levels in the blood can cause hyperosmolality and can 
increase lactic acidosis. 
• Blood sugar levels should be between 60 to 100 mg/dl 
• Because main energy provider to the brain is glucose. 
• Its demands also increases in Hypoxic ischemic encephalopathy 
 
 
 
60 
 
F) MAINTAIN NORMAL CALCIUM 
• In the first two days of life calcium should be given in the maintenance dose of 
4ml/kg/day 
• Maintenance of calcium levels is essential in newborns with HIE 
• It can be given as continuous infusion.  
G)MAINTAIN NORMAL HEMATOCRIT 
• In ventilated babies hematocrit should be above 40% 
• .Anemia as well as polycythemia should be identified and treated correctly  
because  polycythemia can result in  hyperviscosity with adverse 
cardiopulmonary complications. 
F)TREAT THE SEIZURES 
• Initial drug of choice is phenobarbitone  dose is 20mg/kg given intravenously 
and slowly. 
• If seizures is not controlled with initial dose give 10mg/kg every 15 minutes. 
• It can be given upto 40mg/kg 
• Phenytoin can be given if seizures not controlled with maximum dose and 
ususal initial dose is 20 mg/kg 
• Maintainance dose of both drugs are  3-5mg/kg/day given in two divided doses 
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G)FOLLOW UP 
• A complete neurological examination should be done in all newborn with 
moderate and severe HIE 
• Psychometric assessment should be performed in Newborns with HIE around 
one and half years of age. 
H) LONG TERM OUTCOME 
• Newborns with moderate and severe HIE needs to be followed up for long 
periods because they are prone to develop neurological morbidities like seizure 
,developmental delay ,cerebral palsy, 
• Such newborns require careful evaluation and follow up. 
• These babies should be referred to higher centres to provide coordinated 
comprehensive care. 
Hypothermic  neuroprotection   
• Institute  hypothermia  if  less  than  6  hours  old  according  to  the  following  
protocol   
• For  babies  who  are  not  being  treated  with  hypothermia  because  they  
have  a  mild  encephalopathy,  or  have  moderate  /  severe  encephalopathy  
but  are  >  6  hours  old,  it  is  essential  to  avoid  hyperthermia   
Sepsis   
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• Take  a  blood  culture  and  commence  antibiotics  if  there  is  a  possibility  
of  sepsis   
Skin  integrity   
• The  sedated  or  obtunded  infant  is  prone  to  problems  with  skin  integrity.  
Change  position  to  reduce  pressure sores.  
• Make  sure  infant  should  not  lie  on   ice  packs   and  that  the  infant  
should lie  on  wet  sheets   
HYPOTHERMIA 
It acts by decreasing the metabolism in grey and white matters in the brain.It 
also acts by decreasing energy consumption.It reduces the inflammation in the brain 
by reducing the release of inflammatory mediators like platelet activating factors.  It 
decreases secondary neuronal damage by suppressing free radical activity. Death or 
severe disability at 18 months of age is reduced by reducing the extent of brain 
damage 
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Therapeutic   Hypothermia  -  Cooling  16 
Inclusion Criteria    
Infants  >36  gestational age who < 6  hours  old  with  at  least  one  of  the  
following:   
 Apgar  less than 5 at  10  minutes  
 Continued  need  for  resuscitation,  including  endotracheal  or  mask  ventilation,  
at  10  minutes  after  birth   
  Documented Acidosis  -  pH  less than 7.00  in  umbilical  cord  or  any  blood  
sample  (arterial,  venous  or  capillary)  within  60  minutes  of  birth   
 Base  Deficit  ≥  16  mmol/L  in  umbilical  cord  or  any  blood  sample  (arterial,  
venous  or  capillary)  within  60  minutes  of  birth   
Newborns should have 1 or 2 of the below conditions 
Moderate   to   severe  encephalopathy,  consisting  of  ALL  of:   
 Consciousness:  Altered   state  of  consciousness  (reduced  or  absent  response  
to  stimulation)   
 Reflexes:  Abnormal   primitive  reflexes  (weak  or  absent  suck  or  Moro  
response)   
 Tone:  Abnormal   tone  (focal  or  general  hypotonia,  or  flaccid)   
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OR   
 Apparent convulsion or subclinical seizures monitored using Electro 
encephalogram 
PRELIMINARY STEPS BEFORE COOLING 
1. Ensure adequate resuscitation and stabilization ,maintain oxygen saturations 
between 90-95%,maintain blood pressure between 40-50 mmHg and maintain  
glucose >3.5mmol/L 
2. If a decision is made to initiate cooling, then ensure the following: 
 Discuss and advice parents about planned intervention  
 Document the time that cooling is started. 
 Neonate should be kept on an open warmer with the radiant heater. 
 Monitor heart rate,respiratory rate, and continuous saturation monitoring. 
 Measure and document rectal temperature with a digital thermometer 
inserted 2-3 cm from anal verge every 5-10 minutes 
 Core temperature is likely to above rectal temperature 
 Once the decision to cool has been made ,aim to achieve target temperature 
zone within 1 hour. 
PASSIVE COOLING 
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It is a process by which neonate allowed to cool because of absence of thermal 
support.It should be considered while the severity of the neonate clinical 
encephalopathy is being assessed. 
 Neonate should be nursed naked, on an open warmer with radiant heater 
turned off and the nappy should in position. 
 If a head box  oxygen is required, do not humidity:If the baby is on 
ventilator use standard humidifier settings. 
 Timing of commencing hypothermia should be recorded  and document 
temperature every 15 minutes.  
 If the neonate temperature reaches 33.50   C use warm blankets or use 
radiant warmer on manual control to maintain temperature in the target 
range of 33-340   C 
ACTIVE COOLING  
It is usually done to start hypothermia or increase the hypothermic effects.It 
utilizes cold packs .Frozen packs should not be used. 
 
ORGAN DYSFUNCTION IN PERINATAL ASPHYXIA20 
CNS  Hypoxic ischemic encephalopathy, 
intracranial hemorrhage, seizures, long-term 
neurological sequlae  
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Cardiac  Myocardial dysfunction, valvular dysfunction, 
rhythm abnormalities, congestive cardiac 
failure  
Renal  Hematuria, acute tubular necrosis, renal vein 
thrombosis  
Pulmonary  Delayed adaptation, respiratory failure, 
meconium aspiration, surfactant depletion, 
primary pulmonary hypertension  
GI tract  Necrotizing enterocolitis, hepatic dysfunction  
Hematological  Thrombocytopenia, coagulation abnormalities  
Metabolic  Acidosis, hypoglycemia, hypocalcemia, 
hyponatremia  
 
COMPLICATIONS 
• In  the  heart, severe  or  prolonged  asphyxia  result  in  hypoxic  
cardiomyopathy  that  can  present  with  poor  myocardial  contractility  and  
heart  failure.2 
• In  the  kidneys, reduced  blood  flow  results  in  cortical  necrosis  or  acute  
tubular  necrosis  with  features  of  hematuria, proteinuria  and  oliguria. 
• In  the  GIT, hypoxia  predisposes  to  poor  intestinal  motility  and  ileus  
which  leads  to  perforation, ulceration  with  hemorrhagic  necrosis. 
• In  the  hematopoietic  system, asphyxia  depresses  bone  marrow  and  
initiates  intravascular  coagulopathy  ,which  leads  to  thrombocytopenia, 
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prolonged  prothrombin  time  and  partial  thromboplastin  time  with  
evidence  of  bleeding. 
PROGNOSIS 
In asphyxiated newborn  predicting the neurodevelopmental outcome is extremely 
difficult. 
 Explanations for the lack of predictive success include functional and     
anatomic plasticity, interindividual  variability for the same 
              insult, differences in provision of services, and differences 
              in socioeconomic status . 
 Outcome mainly  based on the degree of the injury and the extent of brain 
damage.  
 There is a threshold of injury beyond which the brain is damaged.     Various 
factors can influence the final outcome which include placental-fetal blood 
flow, energy reserves, or presence of cerebral anomalies. 
 It is often difficult to determine the duration of the insult because 
             the vast majority of insults occurs in utero and because 
             adequate fetal surveillance is difficult. 
68 
 
 Certain clinical factors as well as the results of brain imaging studies can help 
identify infants with a poor prognosis . 
PREDICTORS OF NEUROLOGICAL MORBIDITY AND MORTALITY 
AFTER PERINATAL HYPOXIC ISCHAEMIC INSULT20 
• Extended very low APGAR scores (at 20 minutes)  
• Time to establish spontaneous respiration (for 30 or more minutes)  
• Neonatal neurological examination(severe HIE)  
• Brain imaging (USG, MRI)  
• Other investigations (EEG, amplitude integrated EEG, Evoked potentials like 
BERA)  
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DEVELOPMENTAL ASSESSMENT CAN BE DONE IN SEVERAL WAYS 
1)Birth to two  years: 
TRIVANDRUM DEVELOPMENTAL SCREENIG CHART: 
It is a simple screening tool to assess development in large populations below 
two years of age and it is used by the anganwadi  workers .The left end of the 
horizontal dark line indicates age at which 3% of the children passed the item. The 
right end represents age at which 97% of children passed the item. If the child 
chronological age  fall to left side of the line it is considered to be developmental 
delay. 
2 )Two to four years: 
DEVELOPMENTAL ASSESSMENT TOOL FOR ANGANWADI 
Another one is DENEVER DEVELOPMENT SCREENING TESTII 
It is quick and simple screening tool for developmental assessment .It 
comprises of 125 items divided into four categories.1)gross motor2)fine 
motor3)language4)personal and social skills. The child age drawn as a vertical line on 
the chart and examiners administer the items bisected by the lines. Performance of the 
child rated as pass, caution and delay. 
The Vineland Social Maturity Scale measures social competence, self-help 
skills and adaptive behavior from infancy to adulthood. The Vineland scale consists 
of a 117-item interview with a parent or other primary caregiver 
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William T.Mahle et all stated that Bayley scale of infant development has 
sensitivity of 68% and specificity of 80% 
Weschler  intelligence scale for children-Indian adaptation. 
It uses verbal and nonverbal performance scales used to assess verbal and non verbal 
intelligence. Score of the scale ranges from 0 to 20 
Development activities  inventory(DASI)II  
Developmental assessment: Developmental assessment should be done  according to 
the corrected age. 
Assessment of milestones must be in four domains - gross motor, fine motor, 
language, and personal. Corrected age should be mentioned while performing 
developmental assessment. Based on the date of achievement of milestones in a 
particular domain and the expected age of achieving them, the developmental age can 
be calculated. The infants found to be delayed in any domains must undergo 
developmental assessment by using DASII. It should de performed by a clinical 
psychologist.. Motor scale assesses control of gross and fine motor muscle groups. 
Mental scale assesses cognitive, personal and social skills development. DASII can 
assess both mental development index and psychomotor development index. The age 
placement of the item at the total score rank of the scale is noted as the child 
developmental age. This converts the child total scores to his motor age (MoA) and 
mental age(MeA). The respective ages are used to calculate his motor and mental 
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development quotients respectively by comparing them with his chronological age 
and multiplying it by 100. (DMoQ = MoA/CA x 100 and DMeQ = MeA/CA x 100). 
The composite DQ is derived as an average of DMoQ  and  DMeQ. It is 
designed for early detection of development delay with special focus on young 
children with language impairment whose cognitive abilities may not be accurately 
screened with a tool that requires the child to follow spoken instructions. DASI-II 
instructions may be either verbal or visual. There are 67 items which can be 
administered in one or two settings.  Reliability and validity studies found correlation 
coefficient ranging from 0 .87 to 0.95. 
Description of scales 
DASII scale is a point scale with items arranged in ascending order or age placement 
for both motor and mental scales. The items in the two scales are classified into 
content clusters under different areas of development. There are five clusters of motor 
items and 10 clusters of mental items. 
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Motor clusters 
I. Neck control 
II. Body control 
III. Locomotion I (Coordinated movements) 
IV. Locomotion II (Skills) 
V. Manipulation 
Mental clusters 
I. Cognizance (Visual) 
II. Cognizance (Auditory) 
III. Reaching, manipulation and exploring 
IV. Memory 
V. Social interaction and imitative behavior 
VI. Language I (Vocabulary and comprehension) 
VII. Understanding of relationship 
VIII. Differentiation by use, shapes and movements 
IX. Manual dexterity 
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The content clusters have great utility in clinical practice. They may be used in 
analyzing the child’s performance in each area of development obtaining a profile of 
development with indication of areas of delay in development. 
It helps to plan intervention strategy with reference to child’s strengths and 
weaknesses. It aids in effective counseling of parents for home based stimulation 
program. 
Differential diagnosis with DASII 
It is possible not only to identify delays and areas of delays with DASII but 
cluster analysis can also help in differential diagnosis. 
A Down’s syndrome baby will have better motor than  mental profile .A high 
functioning autistic child will have almost normal motor profile and relatively low 
mental but, especially low on language, social interaction. He is likely to do better on 
memory, understanding of relationships or form boards. 
• A cerebral palsy child will score low on motor items, imitative, skills but 
better on  language development, especially receptive language.He may do 
poorly on timed items, like manipulation and manual dexterity clusters. 
• A child with low stimulational and early deprivation may show adequate score 
on motobut lower on mental clusters. 
• Thus, in trained hands, the DASII is a very comprehensive and effective tool 
often considered the gold standard for developmental assessment.  
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• It should be an integral part of any developmental clinic where effective 
intervention is planned. 
Points to Remember 
•  Developmental assessment should be an integral part of NICU (Neonatal 
intensive care unit) 
•  Developmental screening be done in all high risk infant as early as 3-6 months 
of age 
•  DASII (Developmental assessment scales for Indian infants) is a very effective 
comprehensive and useful tool which is standardized in Indian babies 
 
 
 
 
 
JUSTIFICATION OF STUDY 
  Simple  non  invasive clinical tool to select ideal candidate for neuro protective 
therapy, to do early intervention like physiotherapy, developmental assessment, 
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occupational therapy, to minimize disability in future, to counsel the parents 
regarding prognosis early. 
AIM :To determine the ability of THOMPSON SCORE in newborn infant 
with HIE at birth in predicting neurodevelopmental outcome at 9 months of age. 
STUDY POPULATION: Child born with signs of HIE at birth are my study 
population.50 in each arm as exposed  and unexposed group(including 10% lost to 
follow up) 
Exposed-Thompson score more than 10 
Unexposed-Thompson score equal  or less than 10 
Study period-September 2014 to August 2015 
Methodology-Term infants of 37 weeks of gestation or more (as determined by 
the Ballard score) are selected  for the study with clinical signs of HIE developed 
after birth. 
Cranial ultrasound is the objective investigation available.Atleast one cranial 
ultrasound was carried out,usually prior to hospital discharge.100 neonates who met 
the inclusion criteria were  recruited in to study.Of the 100 neonates 8 neonates died 
during neonatal period .Of the 92 who survived,5 neonates lost to followup.  
An detailed developmental assessment was conducted at 9 months of age by 
DASII .Outcome was considered abnormal if there is developmental delay ,defined 
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by  composite developmental quotient .If it less than 70 it is severe delay and if it is 
between 70-85 it is moderate delay. 
T his prospective cohort study was conducted  at the RSRM Hospital NICU and 
the Follow up clinic. 
INCLUSION CRITERIA- 
1)Full term babies with Apgar score( i.e five minute Apgar score of less than or equal 
to 7 
2) Sick infants with symptoms and signs of HIE (respiratory arrest, apnea, posturing, 
movement disorder, impaired sucking, swallowing and feeding) 
EXCLUSION CRITERIA: 
1) Infants> 6hrs of age 
2) Major congenital abnormality or syndromes that include brain dysgenesis 
3) Preterm babies. 
4)Intraventricular hemorrhage. 
5)Neonatal sepsis. 
Infants scored by THOMPSON SCORE within 6 hrs of birth and for 7 consecutive 
days. Infants followed up at 9 months of age. One cranial ultrasound should be done 
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prior to discharge. Detailed neurological and development assessment should be 
done. 
 
It is a clinical tool comprising of a set of clinical signs associated with CNS 
dysfunction. It is used to assess status of a child following birth asphyxia. 
In scoring system, a score of 0 is normal and maximum score is 22 which signifies 
worst possible status of HIE. Infants scoring 1-10 are considered to have mild 
HIE,11-14 have moderate HIE,15-22 are considered to have severe HIE. This is 
modified sarnat scoring system. Infant neurological assessment should be conducted 
using  DASI II by paediatrician. 
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SAMPLING TECHNIQUE 
Consequetive sampling technique was used to collect cases and controls in 
each arm. Epi info 7 was used for data analysis .Incidence of abnormal neurological 
outcome will be estimated along with 95% confidence interval .Identifying  
influencial factors for bad neurological outcome. 
Correlation and regression analysis will be done for Thompson score and 
DASII developmental quotient. 
RESULTS: 
100 neonates who met the inclusion criteria were  recruited in to study. Of the 
100 neonates 8 neonates died during neonatal period .Of the 92 who  survived,5 
neonates lost to followup reasons for which are not known. For understanding 
purpose let us assume exposed as cases and unexposed as controls. 
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Crosstab
23 19 42
53.5% 44.2% 48.8%
20 24 44
46.5% 55.8% 51.2%
43 43 86
100.0% 100.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
MALE
FEMALE
SEX
Total
CASE CONTROL
GROUP
Total
COMPARISON OF SEX DISTRIBUTION AMONG CASES AND CONTROLS 
SEX * GROUP 
 
 
 
 
 
 
DESCRIPTION OF BABIES WITH HIE 
            Among 43 babies in case group 23(53.5%) infants belongs to male sex and 20 
(46.5%) belong to female sex. Among 43 babies in control group 19 (44.2%) belong 
to male and 24(55.8%) belong to female sex. 
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SEX DISTRIBUTION AMONG CASES 
 
 
SEX DISTRIBUTION AMONG CONTROLS 
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PARITY DISTRIBUTION IN CASES AND CONTROLS 
 
 
 
PARITY DISTRIBUTION AMONG CASES GROUP 
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PARITY DISTRIBUTION AMONG THE CONTROL GROUP 
 
 
 
Chi-Square Tests
.745b 1 .388
.419 1 .518
.746 1 .388
.518 .259
.736 1 .391
86
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 21.
00.
b. 
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COMPARISON OF PARITY AMONG CASE  AND CONTROL GROUP 
 
Crosstab
22 20 42
51.2% 46.5% 48.8%
15 15 30
34.9% 34.9% 34.9%
6 8 14
14.0% 18.6% 16.3%
43 43 86
100.0% 100.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
PRIMI
GRAVIDA 2
GRAVIDA 3
PARITY
Total
CASE CONTROL
GROUP
Total
 
 
Chi-Square Tests
.381a 2 .827
.382 2 .826
.337 1 .561
86
Pearson Chi-Square
Likelihood Ratio
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
0 cells (.0%) have expected count less than 5. The
minimum expected count is 7.00.
a. 
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MODE OF DELIVERY * GROUP 
 
 
 
 
MODE OF DELIVERY AMONG CASES GROUP 
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PARITY AND MODE OF DELIVERY AMONG HIE BABIES 
• Among cases 18(41.9%)  babies born by  Normal vaginal delivery and 
25(58.1%) born by LSCS.Among 43 controls 20(46.5%) born by Normal 
vaginal delivery and 23(53.5%) born by LSCS. 
• Among  43 cases, 22 babies born to primi mothers and 15 babies born to 
second gravida mothers and 6 babies born to third gravida mothers.Among 
controls ,20 babies born to primi mothers ,15 babies born to second gravida 
mothers and 8 babies born to third gravida mothers. 
MODE OF DELIVERY AMONG CONTROL GROUP 
 
 
 
 
COMPARISM OF MODE OF DELIVERY AMONG CASES AND CONTROL 
GROUP 
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Crosstab
18 20 38
41.9% 46.5% 44.2%
25 23 48
58.1% 53.5% 55.8%
43 43 86
100.0% 100.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
NVD
LSCS
MODE OF DELIVERY
Total
CASE CONTROL
GROUP
Total
 
 
Chi-Square Tests
.189b 1 .664
.047 1 .828
.189 1 .664
.828 .414
.186 1 .666
86
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 19.
00.
b. 
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CONVULSIONS * GROUP 
 
COMPARISM OF CONVULSION AMONG CASES AND CONTROL GROUP 
 
 
 
CONVULSIONS AMONG CASES 
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CONVULSIONS AMONG CONTROLS 
 
 
 
 
CONVULSIONS  AMONG CASES AND CONTROLS 
                    Among cases 4 developed convulsions i.e 9.3% of cases.Rest 39 cases 
(90.7%) did not develop convulsions.Among 43 controls none of babies had seizures. 
 
 
 
 
 
 
COMPARISM OF CONVULSIONS AMONG CASES AND CONTROLS 
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Chi-Square Tests
4.195b 1 .041
2.360 1 .125
5.740 1 .017
.116 .058
4.146 1 .042
86
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
2 cells (50.0%) have expected count less than 5. The minimum expected count is 2.
00.
b. 
 
 
GROUP 
TOTAL 
CASES CONTROLS 
CONVULSIONS  YES     
COUNT%WITHIN 4(9.3%) 0(0%) 4(4.7%) 
NO    COUNT%WITHIN 39(90.7%) 43(100%) 82(95.3%) 
TOTAL 43(100%) 43(100%) 86 
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COMPARISM OF DEVELOPMENTAL DELAY AMOND CASES AND 
CONTROLS 
 
 
DEVELOPMENTAL DELAY  AMONG CASES 
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Crosstab
28 9 37
65.1% 20.9% 43.0%
15 34 49
34.9% 79.1% 57.0%
43 43 86
100.0% 100.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
PRESENT
ABSENT
DEVELOPMENTAL
DELAY
Total
CASE CONTROL
GROUP
Total
DEVELOPMENTAL DELAY AND DEVELOPMENTAL QUOTIENT 
                   Among cases mean developmental quotient was 71.42 and among the 
controls it was 85.77.Among cases 28(65.1%) had developmental delay, and 
15(34.9%) has normal development .Among the 43 controls 9 (20.9%) has 
developmental delay and 34(79.1%) has normal development  
DEVELOPMENTAL DELAY AMONG CONTROL GROUP 
VV 
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Chi-Square Tests
17.124b 1 .000
15.369 1 .000
17.803 1 .000
.000 .000
16.925 1 .000
86
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 18.
50.
b. 
 
 
 
 
 
 
 
 
 
COMPARISM OF OUTCOME BETWEEN CASES AND CONTROL GROUP 
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OVERALL OUTCOME AMONG CASES 
 
 
 
OVERALL OUTCOME AMONG  CASES AND CONTROLS 
                   Among 43  cases 28 babies i.e 65.1% of babies had overall abnormal 
outcome.Among 43  controls 9 babies i.e 20.9% of babies had overall abnormal 
outcome. 
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Chi-Square Tests
17.124b 1 .000
15.369 1 .000
17.803 1 .000
.000 .000
16.925 1 .000
86
Pearson Chi-Square
Continuity Correctiona
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear
Association
N of Valid Cases
Value df
Asymp. Sig.
(2-sided)
Exact Sig.
(2-sided)
Exact Sig.
(1-sided)
Computed only for a 2x2 tablea. 
0 cells (.0%) have expected count less than 5. The minimum expected count is 18.
50.
b. 
OVERALL OUTCOME AMONG CONTROLS 
 
 
 
Crosstab
15 34 49
34.9% 79.1% 57.0%
28 9 37
65.1% 20.9% 43.0%
43 43 86
100.0% 100.0% 100.0%
Count
% within GROUP
Count
% within GROUP
Count
% within GROUP
NORMAL
ABNORMAL
OVERALL OUTCOME
Total
CASE CONTROL
GROUP
Total
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Group Statistics
43 2.944 .4114 .0627
43 2.883 .3442 .0525
43 38.14 .804 .123
43 38.02 .831 .127
GROUP
CASE
CONTROL
CASE
CONTROL
BIRTH WEIGHT
GESTATIONAL AGE
N Mean Std. Deviation
Std. Error
Mean
Independent Samples Test
1.443 .233 .742 84 .460 .0607 .0818 -.1020 .2234
.742 81.462 .460 .0607 .0818 -.1020 .2234
.000 .991 .660 84 .511 .116 .176 -.234 .467
.660 83.912 .511 .116 .176 -.234 .467
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
BIRTH WEIGHT
GESTATIONAL AG
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
COMPARISON OF BIRTH WEIGHT BETWEEN CASES AND CONTROL 
GROUP 
T-Test 
 
 
 
 
 
 
 
T-Test 
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Group Statistics
43 2.23 .996 .152
43 3.70 1.505 .229
43 5.07 1.261 .192
43 6.00 1.069 .163
GROUP
CASE
CONTROL
CASE
CONTROL
APGAR SCORE1MIN
APGAR SCORE5MIN
N Mean Std. Deviation
Std. Error
Mean
 
 
Independent Samples Test
10.668 .002 -5.324 84 .000 -1.465 .275 -2.012 -.918
-5.324 72.887 .000 -1.465 .275 -2.014 -.917
.778 .380 -3.690 84 .000 -.930 .252 -1.432 -.429
-3.690 81.808 .000 -.930 .252 -1.432 -.429
Equal variances
assumed
Equal variances
not assumed
Equal variances
assumed
Equal variances
not assumed
APGAR SCORE1MIN
APGAR SCORE5MIN
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
 
 
Mann-Whitney Test 
 
Ranks
43 31.52 1355.50
43 55.48 2385.50
86
43 34.51 1484.00
43 52.49 2257.00
86
GROUP
CASE
CONTROL
Total
CASE
CONTROL
Total
APGAR SCORE1MIN
APGAR SCORE5MIN
N Mean Rank Sum of Ranks
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Test Statisticsa
409.500 538.000
1355.500 1484.000
-4.552 -3.445
.000 .001
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
APGAR
SCORE1MIN
APGAR
SCORE5MIN
Grouping Variable: GROUPa. 
 
 
COMPARISM OF THOMPSON SCORE BETWEEN CASE AND CONTROL 
GROUP 
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THOMPSON SCORE AMONG CASES AND CONTROLS 
                      Among  43 cases mean Thompson score was 14.42 and among 43 
controls mean Thompson score was 6.47. 
T-Test 
Group Statistics
43 14.42 3.547 .541
43 6.47 1.932 .295
GROUP
CASE
CONTROL
THOMPSON SCORE
N Mean Std. Deviation
Std. Error
Mean
 
 
Independent Samples Test
7.707 .007 12.913 84 .000 7.953 .616 6.729 9.178
12.913 64.894 .000 7.953 .616 6.723 9.184
Equal variances
assumed
Equal variances
not assumed
THOMPSON SCOR
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
 
 
NPar Tests 
 
Mann-Whitney Test 
 
Ranks
43 64.00 2752.00
43 23.00 989.00
86
GROUP
CASE
CONTROL
Total
THOMPSON SCORE
N Mean Rank Sum of Ranks
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Test Statisticsa
43.000
989.000
-7.633
.000
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
THOMPSON
SCORE
Grouping Variable: GROUPa. 
 
 
COMPARISON OF DEVELOPMENTAL QUOTIENT AMONG CASES AND 
CONTROLS     
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DEVELOPMENTAL DELAY AND DEVELOPMENTAL QUOTIENT 
          Among cases mean developmental quotient was 71.42 and among the controls 
it was 85.77.Among cases 28(65.1%) had developmental delay, and 15(34.9%) has 
normal development .Among the 43 controls 9 (20.9%) has developmental delay and 
34(79.1%) has normal development  
T-Test 
Group Statistics
43 71.42 21.818 3.327
43 85.77 14.851 2.265
GROUP
CASE
CONTROL
DEVELOPMENT
QUOTIENT
N Mean Std. Deviation
Std. Error
Mean
 
 
Independent Samples Test
10.346 .002 -3.565 84 .001 -14.349 4.025 -22.353 -6.345
-3.565 74.043 .001 -14.349 4.025 -22.368 -6.329
Equal variances
assumed
Equal variances
not assumed
DEVELOPMENT
QUOTIENT
F Sig.
Levene's Test for
Equality of Variances
t df Sig. (2-tailed)
Mean
Difference
Std. Error
Difference Lower Upper
95% Confidence
Interval of the
Difference
t-test for Equality of Means
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DISCUSSION 
Hypoxic ischaemic encephalopathy is associated with significant morbidity  
and mortality in full term infant. This study aimed as assessing role of  Thompson 
score in predicting neurodevelopmental outcome in term babies who suffered birth 
asphyxia. 
100 neonates who met the inclusion criteria were  recruited in to study.Of the 
100 neonates 8 neonates died during neonatal period .Of the 92 who survived,5 
neonates lost to followup.  
In this study ,it was found that HIE score was highly specific in detecting 
morbidity among neonates who had moderate and severe HIE.The study also  
revealed  developmental delay was more with increasing HIE score.Others studies 
have shown a similar finding that severely asphyxiated infants have a high mortality 
within first 72 hours of life 
            Among 43 babies in case group 23(53.5%) infants belongs to male sex and 20 
(46.5%) belong to female sex.Among 43 babies in control group 19 (44.2%) belong 
to male and 24(55.8%) belong to female sex. 
Among cases mean birth weight is 2.944 and mean birth weight among 
controls  mean birth weight is  2.883.Mean gestational age among cases was 38 
weeks and among the controls also it was same.In this study, among the cases 
18(41.9%)  babies born by  Normal vaginal delivery and 25(58.1%) born by LSCS. 
Among 43 controls 20(46.5%) born by Normal vaginal delivery and 23(53.5%) born 
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by LSCS. Among  43 cases, 22 babies born to primi mothers and 15 babies born to 
second gravida mothers and 6 babies born to third gravida mothers. Among controls 
,20 babies born to primi mothers ,15 babies born to second gravida mothers and 8 
babies born to third gravida mothers. This study also revealed that among   43 cases 
mean Thompson score was 14.42 and among 43 controls mean Thompson score was 
6.47. 
            In this study it was found that  4   cases  developed convulsions i.e 9.3% of 
cases. Rest 39 cases (90.7%) did not develop convulsions. Among 43 controls none 
of babies had seizures. This study also revealed that mean developmental quotient 
among cases was 71.42 and among the controls it was 85.77.Among cases 28(65.1%) 
had developmental delay, and 15(34.9%) has normal development .Among the 43 
controls 9 (20.9%) has developmental delay and 34(79.1%) has normal development. 
This study also revealed among 43  cases 28 babies i.e 65.1% of babies had overall 
abnormal outcome .Among 43  controls 9 babies i.e 20.9% of babies had overall 
abnormal outcome. 
From the previous studies it was known that positive predictive values for poor 
outcome in moderate and severe HIE is 90% and 100% respectively and negative 
predictive value for the scoring system was 81.4%  sekala D et al. 
C Thompson et all stated that sensitivity and specificity  of  Thompson score 
in predicting neurodevelopmental outcome for maximum score and abnormal on day 
7 is 100% and 93% respectively. 
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Alom R Horn et all stated sensitivity for abnormal outcome is 100% and 61% 
specificity. He  Stated that Thompson score has sensitivity 90% and specificity of 
92% in predicting moderate to severe encephalopathy as compared to aEEG .Positive 
predictive value and negative predictive value of HIE score in predicting 
neurodevelopmental outcome were 89% and 82% respectively in our study. Our 
results are concominant  with  C Thompson et all who found that positive predictive 
value of maximum score is  92 % and negative predictive value of 82% for abnormal 
outcome with sensitivity and specificity of 71% and 96% respectively. 
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CONCLUSIONS: 
• The HIE scoring system used in this study is highly predictive of 
neonatal outcome in terms of early morbidity. 
• Neurological assessment done at 9 months of age using DASII observed 
developmental delay by estimating developmental quotient and 
observing Neurological abnormalities in the form of seizures.. 
Neurological morbidities are correlating to Thompson score. 
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RECOMMENDATIONS 
• It should be performed in all newborns with HIE  so that the clinician can 
identify the infants who are at high risk of developing abnormal 
neurodevelopmental outcome. 
•  It is easy tool for the clinicians to counsel the parents about abnormal 
neurodevelopmental outcome of their babies in earlier periods of life. 
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             NAME 
   
SEX BIRTH WEIGHT 
  
GESTATIONAL 
AGE PARITY 
MODE OF 
DELIVERY    APGAR SCORE  
THOMPSON 
SCORE CONVULSIONS 
DEVELOPMENT 
QUOTIENT
                  (weeks)     1 MIN          5MIN       
1 B/O SARANYA 
   
M 2.6KG 37 1 NVD  2                        3 15 YES 
2 B/O VENKATARAMA    F 3.25KG 38 3 NVD 3                         5 16 NO 
3 B/O KUMARI    F 2.54KG 37 2 LSCS 2                         4 18 YES 
4 B/O DIVYA    F 3.25KG 39 1 LSCS 2                          5 14 NO 
5 B/O MAHADEVI   M 2.75KG 39 2 LSCS 2                         5 13 NO 
6 B/O NANDHINI   F 2.5KG 37 1 LSCS 1                         5 13 NO 
7 B/O SUGANYA   M 3.3KG 38 1 LSCS 2                         6 17 YES 
8 B/O MANJULA   F 3.2KG 39 1 LSCS 2                         5 16 NO 
9 B/O SUMITRA   M 2.56KG 39 1 LSCS 1                         6 17 NO 
10 B/O KALITHA   M 3.06KG 39 1 NVD 3                       6 19 YES 
11 B/O KALA    F 2.5KG 38 2 LSCS 3                        7 12 NO 
12 B/O PARIMALA   F 3.12KG 37 2 LSCS 2                         7 20 YES 
13 B/O RAJESHWARI   M 2.93KG 38 3 NVD 2                        5 17 NO 
14 B/O KULANTHAI THERESA   M 3.3KG 38 2 NVD 2                          4 14 NO 
15 B/O ILAKYA   M 3.41KG 37 1 NVD 1                         3 21 YES 
16 B/O DURGA   F 2.54KG 39 2 NVD 2                         4 16 NO 74% 
17 B/O LAKSHMI   M 2.6KG 39 3 LSCS 5                           7 13 NO 
18 B/O KAVITHA   F 2.7KG 38 1 NVD  3                        6 13 NO 
19 B/O GAJALAKSHMI   F 4.25KG 39 2 LSCS 2                         5 11 NO 
20 B/O KOUSALYA STEPHEN   M 2.86KG 37 1 NVD 1                         4 11 NO 
21 B/O NAGALAKSHMI   M 2.8KG 38 3 LSCS 3                         4 11 NO 
22 B/O PRABHA   M 2.9KG 38 2 NVD 4                         6 12 NO 
23 B/O MAHESHWARI   M 2.5KG 39 1 LSCS 5                         7 14 NO 
24 B/O MEENA   M 2.75KG 37 1 LSCS 1                         3 12 NO 
25 B/O SWAPNA   F 3.2KG 38 2 LSCS 2                         5 19 YES 
26 B/O SUJATHA   F 2.9KG 39 2 LSCS 3                         5 13 NO 
27 B/O MOHANA   M 2.7KG 37 2 NVD 3                          7 11 NO 
28 B/O DHANALAKSHMI   M 2.68KG 37 1 NVD 1                         3 17 NO 
29 B/O SHARMILA   F 2.5KG 38 2 NVD 2                         6 13 NO 
30 B/O REKHA   M 2.93KG 39 3 NVD 3                         5 18 YES 
31 B/O MEENA   M 2.88KG 38 2 NVD 2                         6 17 NO 
32 B/O PRIYA   F 2.80KG 38 1 LSCS 1                        4 12 NO 
33 B/O SARITHA   M 2.75KG 39 1 LSCS 1                         3 19 YES 
34 B/O SIVARANJINI   F 2.9KG 39 1 LSCS 3                         5 20 YES 
35 B/O CHARUMATHI   M 4KG 39 1 LSCS 1                         4 11 NO 
36 B/O SUBADEVI   F 2.75KG 37 2 LSCS 2                         5 11 NO 
37 B/O VIMALA   F 2.67KG 39 3 NVD 3                         7 15 NO 
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38 B/O NADHIYA   F 3KG 38 1 LSCS 1                         3 13 YES 
39 B/O RANJANA   F 3.78KG 37 1 LSCS 2                         5 13 NO 
40 B/O VIJAYALAKSHMI   F 2.76KG 39 1 NVD 2                         6 12 NO 
41 B/O KAVIARASI   M 2.67KG 38 1 LSCS 3                         7 13 NO 
42 B/O ANITHA   M 2.8KG 39 2 NVD 2                         5 15 YES 
43 B/O ELAKIYARAJ   M 3.75KG 38 1 LSCS 3                     5 14 NO 
 
108 
 
 
CONTROLS 
S.
N
o
.
 
N
A
M
E 
SE
X
 
BI
R
TH
 
W
EI
G
H
T 
 
 
G
ES
TA
TI
O
N
A
L 
A
G
E 
PA
R
IT
Y
 
M
O
D
E 
O
F 
D
EL
IV
ER
Y
 
 
 
 
A
PG
A
R
 
SC
O
R
E 
 
TH
O
M
PS
O
N
 
SC
O
R
E 
C
O
N
V
U
LS
IO
N
S 
D
EV
EL
O
PM
EN
T 
QU
O
TI
EN
T 
      (KG) WEEKS     1 
MIN 
5MIN       
1 B/O RAJALAKSHMI M 2.56 37 1 NVD 2 5 10 YES 93% 
2 B/O MARIA M 2.8 38 1 NVD 2 4 4 NO 87% 
3 B/O MUTHULAKSHMI F 2.66 37 2 LSCS 1 3 8 NO 90% 
4 B/O NITHYA M 3 39 1 NVD 1 4 9 NO 88% 
5 B/O NAGESHWARI F 2.75 38 3 LSCS 3 6 5 NO 86% 
6 B/O NANDHINI F 2.7 38 1 NVD 2 7 5 NO 87% 
7 B/O SHALINIDEVI F 2.6 39 3 LSCS 4 7 6 NO 86% 
8 B/O SIVASANKARI M 3.2 37 1 LSCS 3 6 8 NO 90% 
9 B/O UMA F 2.65 38 2 LSCS 2 6 7 NO 83% 
10 B/O MANJU F 2.72 39 2 NVD 3 6 7 NO 117%
11 B/O SARANYA M 2.82 37 1 NVD 1 5 10 NO 50% 
12 B/O GAYATHRI F 2.88 37 1 LSCS 3 7 6 NO 88% 
13 B/O BARGAVI F 3.1 38 1 NVD 5 7 8 NO 105%
14 B/O SREEDEVI F 4 39 2 LSCS 2 6 6 NO 92% 
15 B/O CHANDRIKA M 2.78 39 3 LSCS 1 5 10 NO 97% 
16 B/O HEMA F 2.8 37 1 NVD 6 7 4 NO 86% 
17 B/O SHOBANA M 2.6 38 1 NVD 5 7 5 YES 37% 
18 B/O ARTHY M 2.56 38 3 LSCS 4 6 6 NO 80% 
19 B/O LAVANYA F 2.63 39 2 NVD 5 7 7 NO 98% 
20 B/O PRAGATHEE F 2.58 37 3 LSCS 4 7 5 NO 90% 
21 B/O MEGHA M 2.55 37 2 LSCS 6 7 4 NO 65% 
22 B/O KALPANA F 3.5 39 2 NVD 3 5 9 NO 89% 
23 B/O SHUBHA M 2.9 38 1 LSCS 4 5 8 NO 58% 
24 B/O KAVITHA F 2.68 39 1 LSCS 5 7 5 NO 96% 
25 B/O KANIMOZHI M 2.99 37 1 NVD 6 7 4 NO 98% 
26 B/O SATHYAPRIYA M 2.87 37 2 NVD 3 0 6 NO 87% 
27 B/O JULIE F 2.78 38 3 LSCS 2 5 7 NO 88% 
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28 B/O AMRITA F 2.74 39 1 LSCS 3 7 5 NO 87% 
29 B/O ANUSHA  M 2.9 38 2 LSCS 5 6 4 NO 85% 
30 B/O PRIYA F 2.8 38 3 LSCS 4 5 7 NO 99% 
31 B/O NIRANJANA M 2.6 37 2 NVD 5 6 4 NO 102%
32 B/O ANITHA  F 2.7 39 2 NVD 5 7 5 NO 87% 
33 B/O KALAISELVI M 2.5 37 1 NVD 3 5 10 NO 89% 
34 B/O SHASHIKALA F 2.8 38 1 LSCS 4 6 8 NO 58% 
35 B/O PRIYADARSHINI M 3.1 39 2 NVD 5 7 6 NO 96% 
36 B/O KALARANI M 2.9 38 2 LSCS 3 4 9 YES 60% 
37 B/O MAHALAKSHMI F 2.78 39 1 NVD 5 6 7 NO 89% 
38 B/O BRINDA M 3.2 37 1 NVD 4 7 8 NO 94% 
39 B/O MARIA JYOTHI F 2.6 38 3 LSCS 6 7 5 NO 95% 
40 B/O POORNIMA F 3.5 39 1 NVD 5 6 5 NO 86% 
41 B/O TARA M 3 37 2 LSCS 6 7 8 NO 86% 
42 B/O SUGUNA F 3.2 39 1 LSCS 4 5 4 NO 90% 
43 B/O APARNA F 4 39 2 LSCS 4 7 4 YES 74% 
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ROLE OF THOMPSON SCORE IN PREDICTING NEURO DEVELOPMENTAL OUTCOME IN NEWBORNS. 
 
               Birth asphyxia is a condition of impaired gas exchange  occurring during labour leading to 
progressive hypoxia associated with carbon dioxide retention and significant metabolic acidosis.It is 
an important cause of perinatal mortality and neurological morbidity,Recently new technologies 
have become available to determine cerebral damage more accurately and earlier in perinatal 
course.These include computerized tomography (CT),magnetic resonance imaging(MRI),cerebral  
function monitoring,cranial ultrasound and Doppler ultrasound of middle cerebral artery.These 
modalities are  not available in many neonatal units ,and certainly not in developing countries.There 
is a need for a simple but accurate clinical method of predicting outcome. 
AIM :To determine the ability of THOMPSON SCORE in newborn infant with HIE within 6 hrs of birth 
in predicting neurodevelopmental outcome at 9  months of age. 
JUSTIFICATION OF STUDY:Simple non invasive clinical tool to select ideal candidate for neuro 
protective therapy,to do early intervention like physiotherapy,developmental assessment, 
occupational therapy,to minimize disability in future,to counsel the parents regarding prognosis 
early. 
STUDY POPULATION:Child born with signs of HIE at birth are my study population.50 in each arm as 
exposed  and unexposed group(including 10% lost to follow up) 
Exposed-Thompson score more than 10 
Unexposed-Thompson score equal  or less than 10 
Study period-9 months 
Methodology-Term infants of 37 weeks of gestation or more are selected with clinical signs of HIE at 
birth. 
INCLUSION CRITERIA- 
BOTH 1 AND 2 SHOULD BE PRESENT 
1)INFANTS>37 WEEKS OF GESTATION ADMITTED IN NICUWITH ANY ONE OF FOLLOWING: 
A)APGAR Score<5 at 10 minutes of birth 
B)Continued need for resuscitation including endotracheal or mask ventilation at 10 minutes after 
birth. 
C)Acidosis within 60 minutes of birth( umbilical cord,arterial,or cord PH<7) 
D)Base deficit>16 mmol/lin umbilical cord or any blood sample within 60 minutes of birth. 
2)Altered state of consciousness(lethargy,stupor or coma)atleast one of the following 
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A)Hypotonia 
B)Abnormal reflexes(oculomotor and pupillary abnormality) 
C)Absent or weak suck 
D)Clinical seizures. 
EXCLUSION CRITERIA: 
1)Infants> 6hrs of age 
2)Major congenital abnormality or syndromes that include brain dysgenesis. 
Infants scored by THOMPSON SCORE within 6 hrs of birth and for 7 consecutive days.Infants 
followed up at 3,6,8 months of age.One cranial ultrasound should be done prior to 
discharge.Detailed neurological and development assessment will be done every 3
rd
 month. 
 
 
It is a clinical tool comprising of a set of clinical signs associated with CNS dysfunction. 
It is used to assess status of a child following birth asphyxia. 
In scoring system,a score of 0 is normal and maximum score is 22 which signifies worst possible 
status of HIE. 
Infants scoring 1-10 are considered to have mild HIE,11-14 have moderate HIE,15-22 are considered 
to have severe HIE. 
This is modified sarnat scoring system. 
Infant neurological assessment should be conducted using  DASI II by paediatrician. 
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Development activities screening inventory(DASI)II-It is designed for early detection of development 
delay with special focus on young children with language impairment whose cognitive abilities may 
not be accurately screened with a tool that requires the child to follow spoken instructions.DASI-II 
instructions may be either verbal or visual.There are 67 items which can be administered in one or 
two settings.   
Description of scales 
DASII scale is a point scale with items 
arranged in ascending order or age placement 
for both motor and mental scales. 
The items in the two scales are classified 
into content clusters under different areas of 
development. There are five clusters of motor 
items and 10 clusters of mental items. 
Motor clusters 
I. Neck control 
II. Body control 
III. Locomotion I (Coordinated movements) 
IV. Locomotion II (Skills) 
V. Manipulation 
Mental clusters 
I. Cognizance (Visual) 
II. Cognizance (Auditory) 
III. Reaching, manipulation and exploring 
IV. Memory 
V. Social interaction and imitative behavior 
VI. Language I (Vocabulary and comprehension) 
VII.Understanding of relationship 
VIII. Differentiation by use, shapes and 
movements 
IX. Manual dexterity 
The content clusters have great utility in 
clinical practice. They may be used in analyzing 
the child’s performance in each area of 
development obtaining a profile of development 
with indication of areas of delay in development. 
It helps to plan intervention strategy with referenceto child’s strengths and weaknesses. It aids in 
effective counseling of parents for home based stimulation program. 
Differential diagnosis with DASII 
It is possible not only to identify delays and areas of delays with DASII but cluster analysis 
can also help in differential diagnosis. 
 
 
 
A Down’s syndrome baby will have better motor than mental profile.A high functioning autistic child  
113 
 
will have almost normal motor profile and relatively low onmental but, especially low on language, 
social 
interaction. He is likely to do better on memory,understanding of relationships or form boards. 
A cerebral palsy child will score low onmotor items, imitative, skills but better on language 
development, especially receptive language.He may do poorly on timed items, like 
manipulation and manual dexterity clusters.A child with low stimulational and early 
deprivation may show adequate score on motobut lower on mental clusters. 
Thus, in trained hands, the DASII is a very comprehensive and effective tool often 
considered the gold standard for developmentalassessment. It should be an integral part of any 
developmental clinic where effective intervention is planned. 
Points to Remember 
• Developmental assessment should be an 
integral part of NICU (Neonatal intensive 
care unit) 
• Developmental screening be done in all high risk infant as early as 3-6 months of 
age 
• DASII (Developmental assessment scales for Indian infants) is a very effective 
comprehensive and useful tool which is standardized in Indian babies 
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ÑV Jl×Rp T¥Ym 
êû[ Tô§l× Utßm ARu A±Ï±Ls Es[ ÏZkûRLû[ G°Rp Utßm EPú] LiÓ©¥dL Rôm^u T¬úNôRû] Øû\ûV Tt± 
BWônRp 
 
BWônf£ ¨ûXVm  :  ÏZkûRLs NêL SX UÚjÕYl©¬Ü 
  AWÑ vPôu­ UÚjÕYUû] 
  ùNuû] ­ 600 001. 
TeÏ ùTßm úSôVô°«u ùTVo :  YVÕ 
TeÏ ùTßm úSôVô°«u Gi :  Tô­]m :  Bi    ùTi 
úSôVô°«u ®XôNm : 
 
 
úSôVô° CRû] () Ï±dLÜm : 
 
 
 úUúX Ï±l©hÓs[ UÚjÕY Bn®u ®YWeLs G]dÏ ®[dLlThPÕ. GuàûPV NkúRLeLû[ úLhLÜm, ARtLô] RÏkR 
®[dLeLû[ ùT\Üm YônlT°dLlThPÕ. 
 Sôu Gu ÏZkûRûV Ru²fûNVôLRôu TeúLtL AàU§d¡ú\u. GkR LôWQj§]ôúXô GkR LhPj§Ûm GkR NhP 
£dLÛdÏm EhTPôUp Gu ÏZkûRûV CqYôn®p CÚkÕ ®Xd¡d ùLôs[Xôm Guß A±kÕ ùLôiúPu. 
 CkR BnÜ NmTkRUôLÜm úUÛm CûR NôokR BnÜ úUtùLôsÞm úTôÕm CkR Bn®p TeÏùTßm 
UÚjÕYo Gu ÏZkûR«u UÚjÕY A±dûLLû[ TôolTRtÏ Gu AàU§ úRûY«pûX G] A±kÕ ùLôs¡ú\u. Gu ÏZkûRûV Bn®p 
CÚkÕ ®X¡d ùLôiPôÛm CÕ ùTôÚkÕm G] A±¡ú\u. 
 CkR Bn®u êXm ¡ûPdÏm RLYpLû[Ùm, T¬úNôRû] Ø¥ÜLû[Ùm Utßm £¡fûN ùRôPoTô] RLYpLû[Ùm 
UÚjÕYo úUtùLôsÞm Bn®p TVuTÓj§d ùLôs[Üm AûR ©WÑ¬dLÜm Gu ØÝ U]ÕPu NmU§d¡ú\u. 
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 CkR Bn®p TeÏ ùLôs[ Jl×d ùLôs¡ú\u. Gu ÏZkûRdÏ ùLôÓdLlThP A±ÜûWL°uT¥ SPjÕ ùLôsYÕPu CkR 
BnûY úUtùLôsÞm UÚjÕY A¦dÏ EiûUÙPu CÚlúTu Gußm Eß§ A°d¡ú\u. Gu ÏZkûR«u EPp SXm Tô§dLlThPôúXô 
ApXÕ G§oTôWôR YZdLj§tÏ Uô\ô] úSôndÏ± ùRuThPôúXô EPú] ARû] UÚjÕY A¦dÏ ùR¬®lúTu G] Eß§ A°d¡ú\u. 
 CkR Bn®p Gu ÏZkûRdÏ RûX«p vúLu ùNnÕ ùLôs[ Sôu ØÝ U]ÕPu NmU§d¡ú\u. 
 êuß UôReLÞdÏ JÚ Øû\ ÏZkûRûV UÚjÕY¬Pm Lôi©dL Sôu NmU§d¡uú\u. 
 
TeúLtTY¬u ûLùVôlTm .........................................   CPm ......................... úR§ ...................  
 
LhûP ®Wp (CkR T¥Ym T¥jÕ LôhPlThÓ ×¬kÕ ûLúWûL A°d¡ú\u)  
TeúLtTY¬u ùTVo Utßm ®XôNm ..........................................................................................................  
BnYô[¬u ûLùVôlTm .................................. CPm .............................. úR§ ..................................  
BnYô[¬u ùTVo ................................................................ 
 
 
RLYp T¥Ym 
êû[ Tô§l× Utßm ARu A±Ï±Ls Es[ ÏZkûRLû[ G°Rp Utßm EPú] LiÓ©¥dL Rôm^u T¬úNôRû] Øû\ûV Tt± 
BWônRp 
 
BWônf£«u úSôdLØm, TVuLÞm : 
êû[ Tô§l× Es[ ÏZkûRLû[ ×§VØû\«p EPú] LiÓl©¥dLdá¥V Rôm^u T¬úNôRû] êXm 
AYoL°u êû[ Y[of£ûV ®ûW®p LiÓ©¥jRp.  
 
BnÜ SûPØû\Ls : 
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£¡fûN A°lTRtÏ HtTôÓ ùNnRp CqYôWônf£«u úSôdLUôÏm. EsúSôVô°L[ôL Es[ êû[ Tô§l× 
A±Ï±Ls Es[ ÏZkûRLs CkR BWônf£«p úNojÕd ùLôs[lTÓYôoLs. 
 
AkRWeL RuûU : 
EeLs ÏZkûR«u UÚjÕY T§úYÓLs ªLÜm AkRWeLUôL ûYjÕd ùLôs[lTÓm Utßm ©\ 
UÚjÕYoLs / ®gOô²Ls / CkR Bn®u R²dûLVô[oLs ApXÕ BWônf£ BRWYô[oL°u ©W§ ¨§Ls 
B¡úVô¬Pm AûY ùY°lTÓjRlTÓm. CkR Bn®u Ø¥ÜLs A±®Vp Tj§¬dûLL°p T¬Ñ¬dLlTPXôm. B]ôp 
ùTVûW ùY°«ÓYRu êXm úSôVô°«u AûPVô[m LôhPlTP UôhPôoLs. 
 
Bn®p EeLs TeúLt× Utßm EeLs E¬ûULs : 
CkR Bn®p EeLs ÏZkûRL°u TeúLt× ØÝYÕm EeLÞûPV ®ÚlTjûR NôokRÕ. C§p ¿eLs 
TeúLtLúYô, UßdLúYô, Tô§«p ùY°úV¬PúYô ApXÕ Ï±l©hP úLs®LÞdÏ T§X°dL UßdLúYô EeLÞdÏ ØÝ 
E¬ûU EiÓ GlT¥ CÚkRôÛm EeLs ÏZkûR«u EPp ¨ûXdúLtT EeLs ÏZkûRdÏ ùTôÚjRUô] £¡fûN 
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